NCT05699070 - Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 15, 2023

Primary Completion Date

April 24, 2023

Study Completion Date

June 1, 2023

Conditions

Drug-drug Interaction

Interventions

DRUG

DWC202211 100mg

"DWC202211 for 5 days~Aspirin 100mg"

DRUG

DWC202212 5mg

"DWC202212 for 3 days~Rabeprazole 5mg"

DRUG

DWC202211 100mg + DWC202212 5mg

"DWC202211 + DWC202212 for 5 days~Aspirin 100mg, Rabeprazole 5mg"

Trial Locations (1)

Seoul National University Hospital, Seoul